Quality of breast cancer care: What do we know?

Journal of Clinical Oncology

Volumn 20, Issue 21, 2002, Pages 4381-4393

  Malin, Jennifer L ^a   Schuster, Mark A ^a   Kahn, Katherine A ^a   Brook, Robert H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE RECEPTOR; TAMOXIFEN;

ADULT; AGED; AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; CANCER CHEMOTHERAPY; CANCER REGISTRY; FEMALE; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MEDLINE; PRIORITY JOURNAL; REVIEW; TUMOR VOLUME;

BREAST NEOPLASMS; FEMALE; HUMANS; QUALITY ASSURANCE, HEALTH CARE; QUALITY OF HEALTH CARE; RESEARCH;

EID: 0036842216     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.04.020     Document Type: Review

References (87)

1. Greenlee R, Hill-Harmon M, Murray T, et al: Cancer statistics, 2001. CA Cancer J Clin 51:15-36, 2001
2. Osteen RT, Cady B, Chmiel JS, et al: 1991 National survey of carcinoma of the breast by the Commission on Cancer. J Am Coll Surg 178:213-219, 1994
3. Osteen RT, Cady B, Friedman M, et al: Patterns of care for younger women with breast cancer. J Natl Cancer Inst Monogr 43-46, 1994
4. Breen N, Figueroa JB: Stage of breast and cervical cancer diagnosis in disadvantaged neighborhoods: A prevention policy perspective. Am J Prev Med 12:319-326, 1996
5. Polednak P: Breast cancer in black and white women in New York State: Case distribution and incidence rates by clinical stage at diagnosis. Cancer 58:807-815, 1986
6. Hillner BE, Penberthy L, Desch CE, et al: Variation in staging and treatment of local and regional breast cancer in the elderly. Breast Cancer Res Treat 40:75-86, 1996
7. Winchester JP, Osteen RT, Menck HR: The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age. Cancer 78:1838-1843, 1996
8. Hunter CP, Redmond CK, Chen VW, et al: Breast cancer: Factors associated with stage at diagnosis in black and white women. J Natl Cancer Inst 85:1129-1137, 1993
9. Mandelblatt J, Andrews H, Kao R, et al: Impact of access and social context on breast cancer stage at diagnosis. J Health Care Poor Underserved 6:342-351, 1995
10. McCarthy EP, Burns R, Coughlin SS, et al: Mammography use helps to explain differences in breast cancer stage at diagnosis between older black and white women. Ann Intern Med 128:729-736, 1998
11. Eley JW, Hill HA, Chen VW, et al: Results from the National Cancer Institute Black/White Cancer Survival Study. JAMA 272:947-954, 1994
12. Lannin D, Mathews H, Mitchell J, et al: Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA 279:1801-1807, 1998
13. Ayanian JZ, Kholer BA, Abe T, et al: The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med 329:326-331, 1993
14. Osteen RT, Winchester DP, Hussey DH, et al: Insurance coverage of patients with breast cancer in the 1991 commission on cancer patient care evaluation study. Ann Surg Oncol 1:462-467, 1994
15. Farrow D, Hunt W, Samet J: Geographic variation in the treatment of localized breast cancer. N Engl J Med 326:1097-1101, 1992
16. National Institute of Health: Treatment of early-stage breast cancer. Bethesda, MD, NIH Consensus Statement Online, 1990, http://consensus.nih.gov/cons/081/081_intro.htm
17. Hand R, Sener S, Imperato J, et al: Hospital variables associated with quality of care for breast cancer patients. JAMA 266:3429-3432, 1991
18. Hillner B, McDonal K, Penberthy L, et al: Measuring standards of care for early breast cancer in an insured population. J Clin Oncol 15:1401-1408, 1997
19. Brenin DR, Morrow M, Moughan J, et al: Management of axillary lymph nodes in breast cancer: A national patterns of care study of 17,151 patients. Ann Surg 230:686-691, 1999
20. Bland KI, Menck HR, Scott-Conner CE, et al: The National Cancer Data Base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer 83:1262-1273, 1998
21. Bland KI, Scott-Conner CE, Menck H, et al: Axillary dissection in breast-conserving surgery for stage I and II breast cancer: A National Cancer Data Base study of patterns of omission and implications for survival. J Am Coll Surg 188:586-595, 1999
22. Guadagnoli E, Shapiro CL, Weeks JC, et al: The quality of care for treatment of early stage breast carcinoma: Is it consistent with national guidelines? Cancer 83:302-309, 1998
23. Bickell NA, Aufses AH Jr, Chassin MR: The quality of early-stage breast cancer care. Ann Surg 232:220-224, 2000
24. Ma M, Bell J, Campbell S, et al: Breast cancer management: Is volume related to quality? Clinical Advisory Panel. Br J Cancer 75:1652-1659, 1997
25. Hebert-Croteau N, Brisson J, Latreille J, et al: Variations in the treatment of early-stage breast cancer in Quebec between 1988 and 1994. CMAJ 161:951-955, 1999
26. Hebert-Croteau N, Brisson J, Latreille J, et al: Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer 85:1104-1113, 1999
27. Macleod U, Ross S, Twelves C, et al: Primary and secondary care management of women with early breast cancer from affluent and deprived areas: Retrospective review of hospital and general practice records. BMJ (Clinical Research Edition) 320:1442-1445, 2000
28. Sawka C, Olivotto I, Coldman A, et al: The association between population-based treatment guidelines and adjuvant therapy for node-negative breast cancer: British Columbia/Ontario Working Group. Br J Cancer 75:1534-1542, 1997
29. Olivotto A, Coldman AJ, Hislop TG, et al: Compliance with practice guidelines for node-negative breast cancer. J Clin Oncol 15:216-222, 1997
30. Raabe NK, Kaaresen R, Fossa SD: Analysis of adjuvant treatment in postmenopausal patients with stage II invasive breast carcinoma: A pattern of care study and quality assurance of 431 consecutive patients in Oslo 1980-1989. Acta Oncol 36:255-260, 1997
31. Busch E, Kemeny M, Fremgen A, et al: Patterns of breast cancer care in the elderly. Cancer 78:101-111, 1996
32. Hill DJ, White VM, Giles GG, et al: Changes in the investigation and management of primary operable breast cancer in Victoria. Med J Aust 161:110-111, 114, 118 passim, 1994
33. Shank B, Moughan J, Owen J, et al: The 1993-94 patterns of care process survey for breast irradiation after breast-conserving surgery-comparison with the 1992 standard for breast conservation treatment: The Patterns of Care Study, American College of Radiology. Int J Radiat Oncol Biol Phys 48:1291-1299, 2000
34. Fisher B, Bauer M, Margolese R, et al: Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 312:665-673, 1985
35. Sarrazin D, Le M, Rouesse J, et al: Conservative treatment versus mastectomy in breast cancer tumors with macroscopic diameter of 20 millimeters or less: The experience of the institute Gustave-Roussy. Cancer 53:1209-1213, 1984
36. Veronesi U, Saccozzi R, Del Vecchio M, et al: Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med 305:6-11, 1981
37. National Institutes of Health: Treatment of early stage breast cancer. NIH Consensus Statement, Bethesda, MD, 1990, pp 1-19
38. Young W, Marks S, Kohler S, et al: Dissemination of clinical results: Mastectomy versus lumpectomy and radiation therapy. Med Care 34:1003-1017, 1996
39. Lazovich D, White E, Thomas DB, et al: Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA 266:3433-3438, 1991
40. Ballard-Barbash R, Potosky AL, Harlan LC, et al: Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 88:716-726, 1996
41. Byrne MJ, Jamrozik K, Parsons RW, et al: Breast cancer in Western Australia in 1989: II. Diagnosis and primary management. Aust N Z J Surg 63:624-629, 1993
42. Goel V, Olivotto I, Hislop TG, et al: Patterns of initial management of node-negative breast cancer in two Canadian provinces: British Columbia/Ontario Working Group. CMAJ 156:25-35, 1997
43. Potosky A. Merrill R, Riley G, et al: Breast cancer survival and treatment in health maintenance organization and fee-for-service settings. J Natl Cancer Inst 89:1683-1691, 1997
44. Riley G, Potosky A, Klabunde C, et al: Stage at diagnosis and treatment patterns among older women with breast cancer: An HMO and fee-for-service comparison. JAMA 281:720-726, 1999
45. Morrow M, White J, Moughan J, et al: Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol 19:2254-2262, 2001
46. Lazovich D, Solomon CC, Thomas DB, et al: Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer 86:628-637, 1999
47. Mandelblatt JS, Hadley J, Kemer JF, et al: Patterns of breast carcinoma treatment in older women: Patient preference and clinical and physical influences. Cancer 89:561-573, 2000
48. Moritz S, Bates T, Henderson SM, et al: Variation in management of small invasive breast cancers detected on screening in the former south east Thames region: Observational study. BMJ (Clinical Research Edition) 315:1266-1272, 1997
49. Goy JC, Dobbs HJ, Henderson S, et al: Variations in referral pattern for postoperative radiotherapy of patients with screen-detected breast cancer in the south Thames (east) region. Clin Oncol (R Coll Radiol) 10:24-29, 1998
50. EBCTCG: Tamoxifen for early breast cancer: An overview of the randomised trials. Lancet 351:1451-1467, 1998
51. EBCTCG: Polychemotherapy for early breast cancer: An overview of the randomised trials. Lancet 352:930-942, 1998
52. Osborne C, Clark G, Ravdin P: Adjuvant systemic therapy of primary breast cancer, in Harris J, Morrow M, Lippman M, et al (eds): Diseases of the Breast. New York, NY, Lippincott-Raven Publishers, 1996, pp 548-578
53. Goldhirsch A, Glick J, Gelber R, et al: Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. J Natl Cancer Inst 90:1601-1608, 1998
54. Zujewski J, Liu E: The 1998 St Gallen's Consensus Conference: An assessment. J Natl Cancer Inst 90:1587-1590, 1998
55. National Institutes of Health: National Institutes of Health Consensus Development Conference Statement: Adjuvant therapy for breast cancer - November 1-3, 2000. J Natl Cancer Inst 93:979-989, 2001
56. Guadagnoli E, Shapiro C, Gurwitz J, et al: Age-related patterns of care: Evidence against ageism in the treatment of early-stage breast cancer. J Clin Oncol 6:2338-2344, 1997
57. Grilli R, Alexanian AA, Apolone G, et al: Trends in patterns of care for breast cancer in Italy (1979-1987). Tumori 76:184-189, 1990
58. Johnson TP, Ford L, Warnecke RB, et al: Effect of a National Cancer Institute clinical alert on breast cancer practice patterns. J Clin Oncol 12:1783-1788, 1994
59. Newcomb PA, Carbone PP: Cancer treatment and age: Patient perspectives. J Natl Cancer Inst 85:1580-1584, 1993
60. Du X, Goodwin J: Patterns of use of chemotherapy for breast cancer in older women: Findings from Medicare claims data. J Clin Oncol 19:1455-1461, 2001
61. de Rijke JM, Schouten LJ, Schouten HC, et al: Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, the Netherlands. Ann Oncol 7:677-685, 1996
62. Silliman RA, Demissie S, Troyan SL: The care of older women with early-stage breast cancer: What is the role of surgeon gender? Med Care 37:1057-1067, 1999
63. Demissie S, Silliman RA, Lash TL: Adjuvant tamoxifen: Predictors of use, side effects, and discontinuation in older women. J Clin Oncol 19:322-328, 2001
64. Goy JC, Dobbs HJ: Variation in postoperative radiotherapy delivery for patients with screen-detected breast cancer in the south Thames (east) region. Clin Oncol (R Coll Radiol) 10:30-34, 1998
65. Pearson ML, Ganz PA, McGuigan K, et al: The case identification challenge in measuring quality of cancer care. J Clin Oncol 20:4353-4360, 2002
66. Zippin C, Lum D. Hankey B: Completeness of hospital cancer case reporting from the SEER program of the National Cancer institute. Cancer 76:2343-2350, 1995
67. Cooper G, Zhong Y, Stange K, et al: The sensitivity of medicare claims data for case ascertainment of six common cancers. Med Care 37:436-444, 1999
68. McClish D, Penberthy L, Whittenmore M, et al: Ability of Medicare claims data and cancer registries to identify cancer cases and treatment. Am J Epidemiol 145:227-233, 1997
69. Warren J, Feuer E, Potosky A, et al: Use of Medicare hospital and physician data to assess breast cancer incidence. Med Care 37:445-456, 1999
70. Warren J, Riley G, McBean A, et al: Use of Medicare data to identify incident breast cancer cases. Health Care Financ Rev 18:237-246, 1996
71. Freeman J, Zhang D, Freeman D, et al: An approach to identifying incident breast cancer cases using Medicare claims data. J Clin Epidemiol 53:605-614, 2000
72. National Cancer Institute: About SEER. Bethesda, MD, National Cancer Institute, 2001
73. Wright W: California Cancer Registry. Sacramento, CA, Department of Health Services, 1997
74. NAACCR: Standards for Completeness, Quality, Analysis, and Management of Data. Springfield, IL, North American Association of Central Cancer Registries, 2000 (available at www.naaccr.org)
75. National Cancer Policy Board, Institute of Medicine and National Research Council: Ensuring quality cancer care. Washington, DC, National Academy Press, 1999
76. Cooper GS, Yuan Z, Stange K, et al: Agreement of medicare claims and tumor registry data for assessment of cancer-related treatment. Med Care 38:411-421, 2000
77. Malin JL, Kahn KL, Adams J, et al: Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst 94:835-844, 2002
78. Bickell N, Chassin M: Determining the quality of breast cancer care: Do tumor registries measure up? Ann Intern Med 132:705-710, 2000
79. Brooks J, Chrischilles E, Scott S, et al: Information gained from linking SEER cancer registry data to state-level hospital discharge abstracts. Med Care 38:1131-1140, 2000
80. Doebbeling B, Wyant D, McCoy K, et al: Linked insurance-tumor registry database for health services research. Med Care 37:1105-1115, 1999
81. Potosky A, Riley G, Lubitz J, et al: Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 31:732-748, 1993
82. Green J, Wintfeld N: How accurate are hospital discharge data for evaluating effectiveness of care? Med Care 31:719-731, 1993
83. Fischer E, Whaley F, Krushat W, et al: The accuracy of Medicare's hospital claims data: Progress has been made, but problems remain. Am J Public Health 82:243-248, 1992
84. Dresser M, Whaley F, Feingold L, et al: Clinical quality measurement: Comparing chart review and automated methodologies. Med Care 35:539-552, 1997
85. Cangialose C, Blair A, Borchardt J, et al: Purchasing oncology services. Cancer 88:2876-2886, 2000
86. Komen Foundation: Leading Breast Cancer Organization Partners with ASCO (Online Source). http://www.breastcancerinfo.com/news/article.asp?ArticlelD=72 (last accessed 08/13/01)
87. Skolnick AA: A FACCT-filled agenda for public information: Foundation for Accountability. JAMA 278:1558, 1997